Drug manufacturer to complain over 'disgraceful' NICE secrecy

The manufacturer of an Alzheimer's drug has made a formal complaint to the NHS ombudsman accusing the National Institute for Health and Clinical Excellence of secrecy for refusing to make public the mathematical model it used in the decision to restrict use of the drug.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here